Most brands don't explain how things actually work.
We think that's a problem.
If you have looked into weight loss programs before, you may have noticed:
• Pricing that changes without warning • Processes that are never fully explained • Support that fades after checkout • Memberships that feel hard to leave
That is not accidental.
That is how many systems are designed.
We built IVUSE+ differently.
Clarity is a form of care.
What we believe:
Clarity is care
Simplicity builds trust
People deserve to understand their options
Progress should feel stable
What we avoid:
Confusing pricing
Hidden rules
Artificial urgency
Pressure-based decisions
What most programs do not tell you.
Higher dose often means higher cost. That is not medical. That's margin-driven.
Memberships are just access fees. You're paying to stay enrolled instead of paying for care.
The process is intentionally vague.
So questions come after commitment, not before.
Leaving is harder than joining.
Which usually tells you everything you need to know.
How IVUSE+ works
Complete a medical intake
Licensed provider reviews your information
Medication is shipped
You receive ongoing support
Refills happen on your timeline
Pricing stays consistent
Progress should not cost more.
Many programs increase pricing as dosage increases. We do not.
SEMAGLUTIDE
$285Per Month
All Doses
No Recurring Charges
TIRZEPATIDE
$360Per Month
All Doses
No Recurring Charges
Our pricing is designed to be:
Predictable
Easy to understand
Aligned with long-term success
Free from surprise increases
If you ever feel unsure about what you are paying for, we have failed our own standard.
Who this is for.
IVUSE+ is for you if:
You value clarity over hype
You want consistency
You prefer transparency
You want to understand your care
IVUSE+ is not for you if:
You want shortcuts
You want the cheapest option
You prefer vague promises
You are comfortable with unclear terms
You deserve to know what you are signing up for. You deserve clarity before commitment. You deserve a system that does not punish progress.